Centre for Cannabinoid Therapeutics (CCT) is an interdisciplinary group of world-class researchers and clinicians with expertise in cannabis/cannabinoids under one roof conducting translational research and clinical practice in cannabis, cannabis-derived products and cannabinoids. CCT is "Bud-To-Bedside" and "Bedside-To-Bud". CCT is an example of taking on complex projects and challenges facing the healthcare community in the context of cannabis and cannabinoids as potential therapeutics. Our capabilities include generating real world evidence, investigating real world drug samples, developing novel molecules, drug formulations, drug-receptor level evidence, various disease animal models, and translational research. Our ultimate goal is to investigate and to modulate the endocannabinoid system to align the discoveries for therapeutics development.
Dr. Hance Clarke Dr. Alexander Huang
Dr. Jospeh Fiorellino
Dr. Anuj Bhatia Dr. Mandeep Singh
Leeping Tao, NP, Salima Ladak, NP, PhD, Max Slepian, PhD